Management of Children With Persistent ITP, A Novel Approach
Recruiting
N/A
Interventional Study
Persistent Immune Thrombocytopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 1 – 10
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Assiut University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if mini-pool intravenous immunoglobulin (IVIG) is a safe and effective treatment for children with persistent immune thrombocytopenia (ITP). ITP is a condition that causes low platelet levels and increases the risk of bleeding. The main questions this study aims to answer are:
Can mini-pool IVIG raise platelet levels in children with persistent ITP?
Ca…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:Age 1 - 10 years
* Gender: Males and Females
* Persistent ITP according to ASH definition
* No history of treatment with thrombopoietin agonists
Exclusion Criteria:-History of severe drug adverse events to IVIG
* Previous history of ICH
* Difficult venous access
* Congenital th…
Contacts